logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for pharmaceutical industry professionals · Saturday, April 5, 2025 · 800,398,406 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Pharmaceutical Industry News  •••  Topics  •  Countries  •  U.S. States

Ranibizumab News Monitoring

  • Published on Apr 3, 2025

    Ranibizumab Biosimilar Shows Reduced Efficacy vs Aflibercept in nAMD

    Ranibizumab biosimilar (Ongavia) offers a lower cost alternative for neovascular age-related macular degeneration (nAMD) treatment, resulting in significantly less visual improvement and reduced retinal thickness reduction compared with aflibercept (Eylea …

    Source: The Center for Biosimilars - Label Pending
  • Published on Apr 3, 2025

    Sponsor Pulls Plug on Trials of Add-On AMD Treatment

    The sponsor of two phase 3 clinical trials of an add-on agent to treat age-related macular degeneration has decided to halt both trials after they showed the add-on treatment did not outperform either of the anti–vascular endothelial growth factor agents …

    Source: Medscape - Neutral
  • Published on Apr 3, 2025

    Opthea Announces Termination of ShORe and COAST Trials of Sozinibercept

    Sozinibercept, a novel vascular endothelial growth factor (VEGF) “trap” fusion protein intended for use treating wet age-related macular degeneration (AMD), failed to demonstrate the vision improvements required for success in the phase 3 Combination of …

    Source: HCPLive - Label Pending
  • Published on Mar 31, 2025

    Opthea discontinues COAST and ShORe trials in wet AMD

    Opthea has made the decision to discontinue its COAST and ShORe trials in wet age-related macular degeneration (AMD) following the announcement that the COAST trial failed to meet its primary endpoint. In addition to the termination of ShORe, the company …

    Source: Modern Retina - Label Pending
  • Published on Apr 4, 2025

    This ASX share potentially 'has no value from here', says broker

    ASX biotech share Opthea Limited (ASX: OPT) remains frozen at 60 cents apiece following a failed Phase 3 clinical trial. In an update this week, we learned that Opthea has decided to cease development of its sozinibercept (OPT-302) treatment. This follows …

    Source: The Motley Fool Australia - Neutral
  • Published on Mar 31, 2025

    Opthea discontinues development of sozinibercept in wet AMD

    March 31, 2025 1 min read Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Negative results were reported for …

    Source: Healio News - Neutral
  • «
  • 1
  • »

02 days 23:25:13

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
Load more pharmaceuticals news or search news using your own keywords. There are 800,398,406 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country >
Pharmaceutical Industry News by U.S. State >
Pharmaceutical Industry News Topics >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 03/19/2025

World Media Directory >

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Healthcare & Pharmaceuticals Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Pharmaceutical Industry Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow us on Facebook and connect with us on LinkedIn

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2025 Newsmatics Inc., a publisher of EIN News · All Rights Reserved · Privacy Policy · User Agreement